Barclays PLC Raises Stake in ASP Isotopes Inc. (NASDAQ:ASPI)

Barclays PLC increased its stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI) by 438.5% during the third quarter, HoldingsChannel.com reports. The firm owned 72,330 shares of the company’s stock after buying an additional 58,897 shares during the period. Barclays PLC’s holdings in ASP Isotopes were worth $201,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in ASPI. The Manufacturers Life Insurance Company purchased a new stake in ASP Isotopes during the 3rd quarter worth about $52,000. KKM Financial LLC lifted its holdings in ASP Isotopes by 66.2% during the 3rd quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock worth $63,000 after purchasing an additional 9,000 shares in the last quarter. MetLife Investment Management LLC purchased a new stake in ASP Isotopes during the 3rd quarter worth about $88,000. Verition Fund Management LLC purchased a new stake in shares of ASP Isotopes in the 3rd quarter valued at about $101,000. Finally, Rhumbline Advisers purchased a new stake in shares of ASP Isotopes in the 2nd quarter valued at about $116,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Canaccord Genuity Group assumed coverage on ASP Isotopes in a report on Friday, October 4th. They issued a “buy” rating and a $4.50 price target on the stock. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $4.50 price target on shares of ASP Isotopes in a report on Friday, October 18th.

ASP Isotopes Price Performance

Shares of ASP Isotopes stock opened at $5.03 on Tuesday. The firm has a market capitalization of $359.09 million, a PE ratio of -8.25 and a beta of 3.48. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. ASP Isotopes Inc. has a 12 month low of $1.72 and a 12 month high of $9.33. The business’s 50-day moving average price is $5.93 and its 200-day moving average price is $3.97.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.